Startups channel feed – Endpoints News

Startups channel feed

Looking to run with Big Pharma, a radiopharma startup with backing from Atlas, RA thinks it has the chops to compete

4 years ago

After Big Pharma sparked interest in the US, Ablaze looks to bring radiopharmaceuticals overseas

4 years ago

An RA-backed startup 'ATACs' a novel challenge, looking to spur protein degradation outside the cell

4 years ago

Former Blueprint vets take their new biotech out of stealth, with STAT3 in their sights

4 years ago

A new Flagship startup looks to crack tRNA biology in search for completely new class of therapeutics

4 years ago

Alphabet kickstarts new AI drug discovery outfit with lessons learned from DeepMind protein breakthroughs

4 years ago

Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question

4 years ago

CRISPR Therapeutics co-founder uncloaks an off-the-shelf cell therapy startup with $87M and a lot of fanfare

4 years ago

Bayer backs a George Church spinout trying to turn lab-invented amino acids into a new class of protein therapies

4 years ago

Mozart Therapeutics makes its official debut, jumping into the hot Treg R&D field with some big-name investors backing it

4 years ago

A new Treg player emerges with $46M and backing from Takeda

4 years ago

A new Schrödinger-backed startup emerges from the scientist who mapped the first human GPCR

4 years ago

Crinetics spins out radiopharma efforts into a new company, highlighting the growing field's allure

4 years ago

A star Stanford professor leaves his lab for a startup out to remake psychiatry

4 years ago

Atlas backs a longtime Vertex employee’s quest to bring CF success to numerous other diseases

4 years ago

Tiny player picks up $30M to go after CAR-T's biggest challenges

4 years ago

ARCH unveils its Really Big Neuroscience Company with $500M, an Amgen deal and eyes on depression, Alzheimer's and a lot more

4 years ago

George Church, his students, and top VCs go nationwide with a biotech training camp

4 years ago

On a journey to drastically speed up cell therapy manufacturing, Kytopen lands $30M Series A

4 years ago

Foresite recruits Principia vet Martin Babler — and his old team — to occupy the C-suite of a startup

4 years ago

Eli Lilly gets behind the latest approach to solving gene therapy's delivery problem

4 years ago

Luxturna inventor Jean Bennett starts a new gene therapy company to tackle rare diseases left behind by pharma, VCs

4 years ago

The Endpoints 11: They've got mad money and huge ambitions. It's time to go big or go home

4 years ago

After selling to Genentech, the old Jecure team is back at an RNA-focused startup — and more enthusiastic than ever

4 years ago

First page Previous page 43 44 454647 48 49 Next page Last page